Princeton-based Protega Pharmaceuticals focuses on producing abuse-deterrent pain management products, which go a long way toward reducing substance abuse. In this edition of NJBIZ Conversations, Protega Chief Operating Officer Paul Howe describes the company’s products, its research and what the market looks like.
